- Home
- Equipment
- north america
- patient survival
Show results for
Refine by
Patient Survival Equipment Supplied In North America
21 equipment items found
Manufactured by:IN8Bio Inc. based inNew York, NEW YORK (USA)
INB-200, our DeltEx DRI, is a genetically modified autologous gamma-delta T cell product candidate for the treatment of solid tumors. This is the first genetically engineered gamma-delta T cell therapy to be administered to patients and our initial indication is newly diagnosed Glioblastoma (GBM). Since 2005 the standard of care treatment for GBM has been surgical resection ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
by:T2 Biosystems, Inc. based inLexington, MASSACHUSETTS (USA)
The T2Bacteria® Panel is the first and only FDA-cleared test to identify sepsis-causing bacteria directly from whole blood without the wait for blood ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Adaptate Biotherapeutics is focussed on therapeutic antibodies which harness the potential of patients’ own gamma delta T cells in situ. Gamma delta T cells play a critical role in immune surveillance, recognising malignant/transformed cells through a pattern of stress markers and exerting potent and selective cytotoxicity. The recognition mechanism is not MHC restricted and not ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
by:Abiomed Heart Recovery based inDanvers, MASSACHUSETTS (USA)
The only percutaneous pump approved for right heart support with single vascular access, designed for intelligent patient management. Impella RP with SmartAssist is the only right heart pump equipped with dual-sensor technology to assist with pump management. This technology pumps blood from the inferior vena cava to the pulmonary artery. The pump is inserted with venous access and advanced over ...
Manufactured by:TransMedics, Inc. based inAndover, MASSACHUSETTS (USA)
The Only Heart Device Currently Under FDA Review for Utilized and Unutilized Donor Organs. The OCS Heart is a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state. By monitoring key parameters of the functioning heart, physicians may use their medical judgement to assess a potentially suitable heart’s condition and ...
Manufactured by:RedHill Biopharma Ltd. based inTel-Aviv, ISRAEL
RHB-107 (INN: upamostat) (formerly MESUPRON) is a first-in-class, once-daily, orally-administered, potent inhibitor of serine proteases targeting multiple indications, including COVID-19, cancer, inflammatory lung diseases and gastrointestinal diseases. ...
Manufactured by:TVAX Biomedical, Inc. based inOlathe, KANSAS (USA)
TVAX®’s lead candidate (TVI-Brain-1) is being evaluated for the treatment of brain cancer and targets glioblastomas. The drug candidate has received Fast Track Designation by the US Food and Drug Administration (FDA) to test TVI-Brain-1 in a Phase 2b clinical study for glioblastoma multiforme (GBM). The Fast Track Designation is supported by positive Phase 2 clinical data, as well as ...
Manufactured by:Belmont Medical Technologies based inBillerica, MASSACHUSETTS (USA)
How quickly you start cooling a patient impacts survival and neurological function, especially after a hypoxic-ischemic encephalopathy (HIE) diagnosis or cardiac arrest. That’s why clinicians call on CritiCool, a simple and effective thermal regulating ...
Manufactured by:O-Two Medical Technologies Inc. based inBrampton, ONTARIO (CANADA)
The threat of a chemical-agent release in a crowded area has presented new challenges over the last few years. This environment is as dangerous as that which may be encountered during confined space entry in the industrial setting in atmospheres that are Immediately Dangerous to Life or Health (IDLH). The O-Two CAREvent® CA chemical agent resuscitation environment ventilator has been ...
Manufactured by:Ascelia Pharma AB based inMalmö, SWEDEN
Mangoral is a novel oral imaging agent in development for use in MR-imaging of the liver. Mangoral aims to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with severe kidney impairment. Mangoral is currently in Phase 3 development including the registration-enabling study, ...
Manufactured by:Rotech Healthcare Inc. based inOrlando, FLORIDA (USA)
Rotech offers both invasive and non-invasive ventilators for patients with neuromuscular disease, thoracic restrictive disease, and chronic respiratory failure related to COPD. ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients. ...
Manufactured by:OpGen, Inc. based inRockville, MARYLAND (USA)
Rapid molecular diagnostic solutions for severe infections. Rapid, sample-to-answer results. The Unyvero system uses multiplex PCR technology to simultaneously test for a broad range of microorganisms and antibiotic resistance markers. Unyvero is simple to use and takes ~2 minutes of hands-on time, directly from native sample. Results are displayed on-screen and can be integrated into your ...
Manufactured by:Ardigen based inKraków, POLAND
Bioinformatics Analysis & Drug Discovery in the era of Artificial Intelligence. The digital CRO team brings together scientists and engineers with diverse skill sets, ranging from biology and chemistry to statistics and machine learning. We work with both small startups and big pharmas to leverage digital power in order to enable the development of new therapies. We contribute to the entire ...
Manufactured by:Sequoia Vaccines, Inc. based inSaint Louis, MISSOURI (USA)
Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
Manufactured by:Sepset Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Sepset is developing a blood test for hospitals to identify septic patients in the emergency room (ER) and predict those who will have high risk for organ ...
Manufactured by:Elicio Therapeutics based inBoston, MASSACHUSETTS (USA)
Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most aggressive cancers. Preliminary data have shown that ELI-002 produces a potent mKRAS-specific T-cell response, including both CD4+ and CD8+ ...